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Abstract
Background: The linker histone H1 has a key role in establishing and maintaining higher order chromatin structure 
and in regulating gene expression. Mammals express up to 11 different H1 variants, with H1.2 and H1.4 being the 
predominant ones in most somatic cells. Like core histones, H1 has high levels of covalent modifications; however, the 
full set of modifications and their biological role are largely unknown.
Results: In this study, we used a candidate screen to identify enzymes that methylate H1 and to map their 
corresponding methylation sites. We found that the histone lysine methyltransferases G9a/KMT1C and Glp1/KMT1D 
methylate H1.2 in vitro and in vivo, and we mapped this novel site to lysine 187 (H1.2K187) in the C-terminus of H1. This 
H1.2K187 methylation is variant-specific. The main target for methylation by G9a in H1.2, H1.3, H1.5 and H1.0 is in the C-
terminus, whereas H1.4 is preferentially methylated at K26 (H1.4K26me) in the N-terminus. We found that the readout 
of these marks is different; H1.4K26me can recruit HP1, but H1.2K187me cannot. Likewise, JMJD2D/KDM4 only reverses 
H1.4K26 methylation, clearly distinguishing these two methylation sites. Further, in contrast to C-terminal H1 
phosphorylation, H1.2K187 methylation level is steady throughout the cell cycle.
Conclusions: We have characterised a novel methylation site in the C-terminus of H1 that is the target of G9a/Glp1 
both in vitro and in vivo. To our knowledge, this is the first demonstration of variant-specific histone methylation by the 
same methyltransferases, but with differing downstream readers, thereby supporting the hypothesis of H1 variants 
having specific functions.
Background
In eukaryotic cells, DNA is packaged into chromatin. The
building block of chromatin is the nucleosomal core par-
ticle containing a histone octamer (formed by the his-
tones H2A, H2B, H3 and H4) around which 147 bp of
DNA (147 bp) are wrapped [1]. The linker histone H1
binds to the DNA between the nucleosomal core parti-
cles, and is essential to stabilise higher order chromatin
structures [2].
Human cells possess up to 11 H1 variants, all consisting
of a short N-terminal tail, a globular core domain and a
C-terminal tail, making up approximately 50% of the
whole protein [3,4]. H1.0 is mainly expressed in termi-
nally differentiated cells. H1.1 expression has to date only
been reported for a subset of tissues. H1.2 to H1.5 are
expressed in almost all cells, with H1.2 and H1.4 being
the predominant variants in most somatic cells [5]. The
variants H1t, H1T2, H1oo and HILS1 are only found in
germ cells [3,4]. Expression of H1x has only been investi-
gated in a limited number of cell types [6]. H1 variants
were shown to have a distinct nuclear localisation; for
example, H1.2 seems to localize preferentially to euchro-
matic regions, whereas H1.4 is enriched in heterochro-
matic regions [7,8]. Whether somatic H1 variants have
specific functions is subject to ongoing research [4]. Sin-
gle knockout H1 variants in mice show upregulation of
other H1 variants and relatively mild phenotypes [9].
However, knockout of three H1 variants leads to a 50%
reduction of overall H1 amount and is embryonically
lethal [10]. This highlights the potential importance of
histone H1 in maintaining chromatin integrity, and sug-
gests two possible functions of H1 variants: a general one
redundant among H1 variants and related to the forma-
* Correspondence: daujat@immunbio.mpg.de
, schneiderr@immunbio.mpg.de
MPI for Immunobiology, Stübeweg 51, 79108 Freiburg, Germany
Full list of author information is available at the end of the articleWeiss et al. Epigenetics & Chromatin 2010, 3:7
http://www.epigeneticsandchromatin.com/content/3/1/7
Page 2 of 13
tion of higher order chromatin, and an individual, gene-
specific one.
Covalent modifications of histones such as lysine meth-
ylation are involved in the regulation of all DNA-based
processes. Methylation marks are catalysed by histone
lysine methyl transferases (HKMTs) using S-adenosyl
methionine (SAM) as the methyl group donor. The func-
tion of histone lysine methylation depends on the specific
site and the methylation state (mono-, di- or trimethy-
lated) [11]. However, not all HKMTs can catalyse the
trimethylation state. G9a/KMT1C and the G9a-like pro-
tein 1 (Glp1/KMT1D) were initially described as enzymes
that could mono- and dimethylate H3 on Lys9 (H3K9) in
euchromatic regions, leading to repression of specific
genes [12,13]. Knockout of either of these two enzymes is
lethal at embryonic day (E9.5). Both knockouts result in
drastic reduction of H3K9 mono- and dimethylation,
leading to induction of specific genes. Furthermore, het-
erochromatin protein 1 (HP1), which binds to H3K9me2/
me3, is relocalized in G9a/Glp1-deficient ES cells.
Although G9a and Glp1 can independently methylate
H3K9 in vitro, they form a heteromeric complex in vivo,
explaining their similar phenotypes and the lack of
redundancy [14]. Interestingly, some HKMTs have more
than one target; for example, G9a was reported to methy-
late both H3 and H1.4 [15,16].
Most of the methylation marks characterized to date,
are located in the N-terminal tails of the core histones H3
and H4. Posttranslational modifications of the linker his-
tone H1 are less well studied. The best characterised H1
modification is phosphorylation [17,18]. This phosphory-
lation is cell cycle-dependent, reaching a maximum in M
phase [17], and is mainly catalysed by cdk type kinases
[17]. H1.4K26 methylation was the first methylation site
discovered in H1. This methylation has been reported to
be catalysed by Ezh2 as part of the PRC2 complex and
G9a [16,19]. H1.4K26me2 is bound by HP1, leading to
transcriptional repression, whereas phosphorylation of
H1.4S27 impairs HP1 binding [20]. Technical improve-
ments in mass spectrometry (MS) have lately led to the
identification of new modification sites including methy-
lation on various human H1 variants [18], but as yet their
functions are unknown.
However, getting complete sequence coverage of H1 in
MS analysis is very difficult, and several potential modi-
fied sites might be missed during the analysis. We sought
to overcome this problem by using a candidate approach
to identify HKMTs with activity on H1 and their target
sites. We report for the first time that G9a and Glp1 are
enzymes with activity towards the C-terminal tail of H1
both in vitro and in vivo, and we have mapped the methy-
lation site on H1.2 to K187. We further show that methy-
lation by G9a/Glp1 is H1 variant-specific, as G9a and
Glp1 methylate preferentially H1.4K26 and H1.2K187 but
not the corresponding lysines on H1.2 and H1.4, respec-
tively. Additionally, these two methylation marks differ in
their readout, as HP1 binds to methylated H1.4K26 but
not to H1.2K187. Similarly, JMJD2D demethylates
H1.4K26me but not H1.2K187me. Interestingly, the
H1.2K187 methylation is constant over the cell cycle, in
contrast to C-terminal H1 phosphorylation. Our data
suggest that H1 variant-specific functions can be
achieved through differential methylation of specific resi-
dues in vivo.
Results
K187H1.2 is a new methylation site in the C-terminus of 
H1.2
To find HKMTs specifically modifying histone H1 and to
identify new methylation sites, we followed a candidate
approach. A collection of described and potential
HKMTs (all containing a SET domain) were recombi-
nantly expressed and assayed for activity on HEK293 core
nucleosomes and H1. Recombinant G9a and its interac-
tion partner Glp1 had the strongest methylation activity
towards histone H1 (Figure 1a), whereas the other
enzymes did not modify H1 or were much less active on
H1. Note that the enzymes used for these assays also
methylate core histones, as reported previously [15,21],
thus serving as a positive control (Figure 1a; see Addi-
tional file 1). We then focused our further analyses on the
HKMTs most active on H1: G9a and Glp1.
Despite H1.2 being the most abundant H1 variant in
many tissues and cell lines [5], the only characterized his-
t o n e  H 1  m e t h y l a t i o n  s i t e  i s  K 2 6  i n  t h e  N - t e r m i n u s  o f
H1.4 [19,20,22]. This prompted us to ask whether G9a
and Glp1 can also methylate H1.2. Figure 1b shows that
both enzymes can indeed methylate recombinant H1.2 in
vitro. Interestingly, recent MS studies [18] suggested the
existence of additional methylation sites, most likely
located in the core region and the C-terminus of H1,
which has been implicated in targeting and chromatin
binding of H1. To investigate if G9a and/or Glp1 can
methylate the C-terminus of H1.2, we assayed both
enzymes on the H1.2 C-terminus (116-213). Both recom-
binant G9a and Glp1 (Figure 1b) and immunoprecipi-
tated, eukaryotically expressed full-length G9a/Glp1
(data not shown) can methylate the C-terminus of H1.2,
suggesting the presence of an additional G9a/Glp1-spe-
cific methylation site in the H1.2 C-terminus.
Next, we attempted to map this new methylation site in
the C-terminus of H1.2. Because the C-terminus of H1 is
extremely lysine-rich (a total of 40 lysine residues) (Figure
2a), a cluster mutation approach of the H1.2 C-terminus
was first undertaken. All lysines were grouped into 10
clusters (Figure 2b) and replaced by non-lysine amino
acids. These recombinantly expressed proteins were then
used for in vitro methylation assays with immunoprecipi-Weiss et al. Epigenetics & Chromatin 2010, 3:7
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Figure 1 G9a and its interaction partner Glp1 methylate H1. (a) Candidate methylation assay on core nucleosomes and H1. Indicated HKMTs 
fused to GST (see also Methods) were used for methylation assays to identify enzymes methylating H1. Core nucleosomes (purified from HEK293) were 
mixed with H1 as substrates. All enzymes were tested in (lane 1) Tris, (lane 2) PBS, (lane 3) MAB and (lane 4) R methylation buffers. Incorporation of the 
methyl group from the donor adenosyl-L-methionine S-[methyl-3H] was detected by autoradiography (for a specificity control see Additional file 1). 
(b) Recombinantly expressed SET domains of Glp1 (610-917) and G9a (682-1000) and recombinant H1.2FL and H1.2CT were used for methylation as-
says. G9a and Glp1 methylate the H1.2 C-terminus (CT). Ponceau staining of the membrane (Pon, upper panels) and autoradiography (Rad, lower pan-
el) are shown.Weiss et al. Epigenetics & Chromatin 2010, 3:7
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Figure 2 G9a and Glp1 methylate H1.2K187. (a) Amino acid sequence of the C-terminal tail of H1.2. Lysines as potential methylation sites are high-
lighted in grey. (b) Cluster mutation approach to map methylation sites in the C-terminal part with its 40 potential sites. Cluster definitions and their 
substituting amino acid sequence are depicted. All lysines in the C-terminal tail of H1.2 were classified into 10 clusters (grey rectangles). Cluster 12 is 
a fusion of clusters 1 and 2. (Upper) Wild-type H1.2 sequence; (lower) the substituting amino acids. (c) The methylated site is between amino acids 
187 and 196. Methylation assay of the cluster mutation constructs with immunoprecipitated Glp1. Used constructs are schematically indicated on top. 
Grey rectangles, mutated clusters; white rectangles, wild-type clusters. In addition, all constructs carry a lysine to arginine mutation introducing an 
arginase C cutting site. (Upper panel) Ponceau (Pon) staining as a loading control. The different migration levels of the constructs are due to the sub-
stitutions and replacements of different numbers of uncharged and positively charged lysines by uncharged amino acids. Note a strong reduction in 
methylation in lane 16, corresponding to a cluster 8 mutation (mutated cluster containing K187 is indicated by asterix). (d) Methylation assay with 
wild-type H1.2CT, H1.2CT K172R, H1.2CT K187R, H1.2CT K172R and K187R and wild-type H1.2CT (2× z-tag) as substrates. Mutation of K187 results in a 
strong reduction of methylation by immunoprecipitated Glp1. (Upper panel) Pon; (lower panel) autoradiography (Rad). Wild-type H1.2CT (2× z-tag) 
was added to the methylation assays as an internal control of methyltransferase activity (lanes 5 to 8). (e) Methylation assays on peptides. Peptides 
containing unmodified K187, monomethylated K187 and dimethylated K187 and immunoprecipitated G9a were used for methylation assay. Rad is 
shown. Note that unmodified and monomethylated peptide were methylated to similar extents, whereas the dimethylated peptide was not methy-
lated.Weiss et al. Epigenetics & Chromatin 2010, 3:7
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tated, eukaryotically expressed Glp1 and G9a. As shown
in Figure 2c, the H1 in which the cluster of amino acids
187 to 196 is mutated (lane 16) was markedly less methy-
lated by Glp1 than the wild type C-terminus (lane 4) and
all other constructs. This suggests that the main methyla-
tion site for Glp1 in the C-terminus resides in this amino
acid stretch. Identical results were obtained for G9a (data
not shown).
To identify the lysine residues methylated by G9a and
Glp1, individual lysines in this cluster were mutated,
starting with Lys187. Mutation of Lys187 to Arg resulted
in almost complete loss of methylation activity of the C-
terminus of H1.2 (Figure 2d, lanes 1 and 3), but not of
other lysines in the cluster (data not shown). As a speci-
ficity control, Lys172, which is within a similar sequence
motif (AKS) was also mutated; however, this mutation
did not reduce methylation activity by Glp1 (Figure 2d,
lane 2). To exclude the possibility that the lower methyla-
tion of the K187R mutant was due to inhibiting activities
in the reaction, wild-type H1.2 CT (2× z-tag) was added
as an internal control. Note that wild-type H1.2 CT (2× z-
tag) becomes equally methylated in all the reactions (Fig-
ure 2d, lanes 5 to 8). Specificity was confirmed by tandem
MS (MS/MS) analysis of the in vitro methylated H1.2
(data not shown). In parallel, peptides spanning amino
acids 182 to 193 were used as substrates in methylation
assays. Peptides unmethylated on K187 could be methy-
lated by G9a (Figure 2e). For all these assays, identical
results were obtained for Glp1 and G9a (data not shown).
G9a and Glp1 had been previously reported to catalyse
mono- and dimethylation [12,23]. Indeed, G9a and Glp1
can dimethylate a monomethylated K187 peptide but
cannot trimethylate a dimethylated K187 peptide, again
indicating that both enzymes can catalyse the mono- and
dimethylation (Figure 2e, data not shown) as shown for
H3K9 in vitro and in vivo [12,14,24]. Together, these data
identify K187 as a new methylation site within the C-ter-
minus of H1.2 and show that the HKMTs G9a and Glp1
can methylate this site in vitro.
K187H1.2 is methylated by G9a and Glp1 in vivo
To confirm that G9a and Glp1 can also methylate K187 of
H1.2 in vivo, RNA interference (RNAi) analysis was per-
formed. HEK293 cells were used with either non-target
negative control small interfering siRNA or simultane-
ously with two siRNAs against G9a and Glp1 to knock
down both enzymes. At 42 hours and 72 hours after
transfection of the siRNAs, a reduction in G9a RNA to
approximately 20% and Glp1 to 30% was detected by RT-
PCR (Figure 3a), and this knockdown was confirmed by
western blotting (data not shown).
Histones were then acid-extracted from these cells and
prepared by derivatization with D0- and isotopic D5-pro-
pionic anhydride for quantitative proteomic analysis.
Figure 3 G9a and Glp1 methylate H1.2K187 in vivo. (a) Reverse 
transcription PCR analysis of siRNA-transfected cells harvested at indi-
cated time points. HEK293 cells were either transfected with a control 
siRNA (negative control; NK) or simultaneously with siRNAs against G9a 
and Glp1 (double knockdown; dkn). mRNA levels were normalised to 
β-actin expression. The mRNA levels of G9a and Glp1 in the control 
cells were set as 1 and levels in the double knockdown cells calculated 
as the ratio of this level (light grey, G9a; dark grey, Glp1). (b) MS analysis 
of H1.2 after knockdown. Full MS result showing the quantitative com-
parison of H1 peptides from control and G9a/Glp1 double knockdown 
samples. We observed an approximate twofold decrease in a peptide 
(414.750 m/z) from the G9a/Glp1 dkn sample compared with the con-
trol. (c) This peptide at 414.750 m/z was sequenced by MS/MS experi-
ments and determined to be the peptide containing the K187 
monomethylation mark. The dimethylation of H1.2K187 might have 
escaped our mass-spectrometric analysis by being below of our cur-
rent detection threshold.
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After derivatization, control and knockdown samples
were mixed equally; they could be distinguished because
of a mass difference corresponding to a 5 Da shift. Two
sets of peaks corresponding to a 2.5 Da shift were seen,
which is consistent with D0- and D5-propionyl labelling
for a 2+ charged peptide. The D0 labelled peptide from
the G9a/Glp1 knockdown sample was decreased by
approximately two fold compared with the control (Fig-
ure 3b), and MS/MS analysis of this D0 peak (Figure 3c)
confirmed that this peptide contained the sequence pr-
AAKprmeSAAKpr (pr = propionyl amide, +56 Da). To con-
trol for enzyme specificity, the effect of the knockdown
on other histone modifications was analysed, and as pre-
viously described [16], a reduction in H1.4K26me and
H3K9me was seen, whereas H3K27me and H4K20me did
not change (Additional file 2). In summary, this demon-
strates that K187 of H1.2 is methylated in vivo and that
G9a and Glp1 can mediate this methylation.
K187 methylation by G9a/Glp1 is H1 variant-specific
Up to this point, our studies had been focused on methy-
lation of the H1.2 C-terminus. Because it had recently
been described that G9a can methylate K26 on H1.4 [16],
we then investigated whether H1.2 can also be methy-
lated by G9a or Glp1 at K26 or at the neighbouring K27
(Figure 4a). Both lysines in full-length H1.2 were
mutated, and methylation assays performed in vitro.
Whereas mutation of K187 resulted in a strong decrease
in methylation (Figure 4b; lanes 1 and 11 versus lanes 3
and 13), mutation of K26 and K27 did not impair H1.2
methylation by Glp1 or G9a (Figure 4b, lanes 2 and 12).
By contrast, mutation of H1.4K26 resulted in an almost
complete loss of methylation (Figure 4b, lanes 8 and 18)
whereas mutation of K186 (corresponding to K187 in
H1.2) did not affect the methylation of H1.4 by Glp1 and
G9a (Figure 4b, lanes 9 and 19). Thus, G9a/Glp1 methy-
lated H1 in a variant-specific manner, preferentially tar-
geting the N-terminus of H1.4, but the C-terminus of
H1.2.
These results prompted us to investigate whether the
other major H1 variants are methylated by G9a/Glp1 on
the N- or C-terminus. First, in vitro methylation assays
were performed, using recombinant H1.3, H1.5, and the
more divergent variant H1.0; the latter is mainly
expressed in terminally differentiated cells. All of the H1
variants analysed could be methylated by G9a/Glp1 (Fig-
ure 4c). To distinguish between N- and C-terminal meth-
ylation, H1 was digested after the methylation reaction
with chymotrypsin, which cleaves the H1 C-terminus at
position F105 [17]. G9a/Glp1 methylated preferentially
the N-terminus of H1.4, whereas they methylated prefer-
entially the C-termini of other variants (Figure 4d).
Together, these data demonstrate that G9a and Glp1
methylate residues within H1 in a variant-specific fash-
ion. H1.4 is specifically methylated at the N-terminus at
K26 and H1.2 at the C-terminus at K187, but not the cor-
responding lysines on H1.2 and H1.4, respectively. Fur-
thermore, the C-terminus of H1 is the main target for
G9a/Glp1-mediated methylation in most somatic H1
variants.
H1.2K187 methylation is cell cycle-independent
Histone H1 phosphorylation is also mainly localised to
the C-terminus. This C-terminal H1 phosphorylation is
highly cell cycle-regulated [17], reaching a maximum in
G2/M. Based on this, we investigated if H1.2K187 is also
cell cycle-regulated. Therefore, HEK293 cells were syn-
chronised and H1 isolated at different time points for
quantitative MS analysis. H1.2K187 methylation levels
stayed relatively constant during the cell cycle (Figure 5a),
indicating that H1.2 C-terminal phosphorylation and
H1.2K187me may act independently of each other.
H1.2K187 and H1.4K26 have different downstream readers
To identify novel, methylation-dependent H1 binding
proteins, we followed an unbiased approach initially,
using peptide affinity purifications. We did not detect any
novel H1 methylation-specific binding proteins (data not
shown), thus we switched to a candidate approach. We
showed previously [20] that HP1 binds specifically to
methylated K26 of H1.4. Because H1.2K187 and H1.4K26
are methylated by the same enzymes, we investigated if
HP1 could also bind to methylated H1.2K187. Recombi-
nant HP1β and γ were expressed and assayed for binding
to K187me2 in peptide affinity purifications. The recom-
binant HP1β and γ bound to methylated H1.4K26me2
(Figure 5b, lane2) but not to H1.2K187me2 (lane 4). To
confirm this with endogenous proteins, the peptide affin-
ity purifications were repeated using HeLa nuclear
extract as HP1 source. There was specific binding of
endogenous HP1 to H1.4K26me2 (Figure 5c, lane 2), but
not to H1.2K187me2 (Figure 5c, lane 6). These data indi-
cate selective recognition by HP1: H1.4K26me2 is specifi-
cally bound by HP1 whereas H1.2K187me2 is not.
The ankyrin repeats of G9a and Glp1 have been shown
to bind specifically to H3K9me1/2 and it has been sug-
gested that this binding could be involved in the recruit-
ment of the enzymes. Therefore, we investigated if they
could also bind to methylated H1. We did not observe any
specific binding of Glp1 (Figure 5d) (or G9a, data not
shown) to either H1.4K26me2 or H1.2K187me2, arguing
against a binding of G9a/Glp1 to its H1 substrate sites.
To gain further insight into regulation of K187 methyla-
tion we investigated whether the jumonji-C type histone
demethylase JMJD2D/KDM4 (which can reverse dimeth-
ylation to monomethylation) could demethylate
H1.2K187me2, as shown for H1.4K26me2 [16].
H1.2K187me2 and H1.4K26me2 peptides were first dem-Weiss et al. Epigenetics & Chromatin 2010, 3:7
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Figure 4 Variant-specific methylation of H1 by G9a/Glp1. (a) Alignment of H1 variants H1.2, H1.3, H1.4, H1.5 and H1.0. Amino acids identical in at 
least three variants are highlighted in blue. The regions around H1.4K26 and H1.2K187 are boxed. (b) H1.4K26 and H1.2K187 are G9a and Glp1 targets. 
Methylation assay on indicated H1.2 and H1.4 mutants using (left) immunoprecipitated Glp1 and (right) G9a. Note that the high expression of H1 led 
to partial N-terminal degradation of some constructs in bacteria. (Upper panels) Ponceau (Pon) staining: *degradation fragments. (Lower panels) Au-
toradiography (Rad). (c) H1.2, H1.3, H1.4, H1.5 and H1.0 were methylated by G9a and Glp1. Methylation assays on recombinant human H1 variants 
using immunoprecipitated G9a and Glp1. (Upper panels) Ponceau (Pon) staining; (lower panels) autoradiography (Rad). (d) Methylation assays on hu-
man recombinant H1 followed by chymotrypsin digestion, which separates the N-terminus and core from the C-terminus. Only the N-terminus and 
core of H1.4 is a major G9a/Glp1 target whereas H1.2, H1.3, H1.5 and H1.0 are methylated by G9a/Glp1 preferentially in the C-terminal part. Autora-
diography (Rad) is shown (loading control in Additional file 3).
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Figure 5 H1.2K187 methylation is cell cycle-independent and HP1 binds only to methylated H1.4K26. (a) H1.2K187me is cell cycle-indepen-
dent. Quantitative MS analysis of H1 extracted from unsynchronized HEK293 cells and synchronized cells in G1 and M phase. A selected ion monitoring 
experiment was used on the ion 414.745 m/z (corresponding to H1K187 methylation) to monitor the levels of methylation. Normalisation was done 
relative to unsynchronized cells. (b) Recombinant HP1 binds to H1.4K26me2 but not to H1.2K187me2. Peptide affinity purification of recombinant 
HP1β and γ (GST fusion protein). The upper panels show the anti GST WB of the elution and lower panels the Coomassie staining of eluted fraction. 
(c) Endogenous HP1 binds to H1.4K26me2 but not H1.2K187me2. Western Blot analysis of peptide affinity purification of nuclear extracts (HeLa ex-
tracts) with HP1α/β specific antibody. (d) Glp1 does not bind to H1.4K26me2 or H1.2K187me2. Western Blot analysis of peptide affinity purification of 
nuclear extracts (HeLa extracts) with Glp1 specific antibody. (e) JMJD2D demethylates H1.4K26me2 only. Methylation assay with G9a and Glp1 after 
demethylation of peptides by JMJD2D (Rad).
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ethylated and then assayed for remethylation with G9a
and Glp1. This assay is indirect but very sensitive, as low
levels of demethylation are sufficient to allow remethyla-
tion. Incubation of the dimethylated H1 peptides with
recombinant JMJD2D allowed remethylation by G9a/
Glp1 of the H1.4K26 peptide (Figure 5e, lane 1) but not of
the H1.2K187 peptide (lane 4). Thus H1.4K26me2 but
not H1.2K187me2 can be demethylated by JMJD2D.
Together, these results show that despite being methy-
lated by the same HKMTs, H1.4K26 and H1.2K187 meth-
ylation are read and removed by different proteins,
suggesting novel variant-specific functions.
Discussion
Our data show that K187 in histone H1.2 is a new target
of HKMTs G9a and its interaction partner Glp1 in vitro
and in vivo, as confirmed by mutation analysis, knock-
down experiments and MS analysis. To our knowledge,
this is the first characterisation of a methylation site and
its corresponding methylating enzymes in the C-termi-
nus of histone H1. G9a and Glp1 were found to be in het-
eromeric complexes and to share high sequence
homology, and in the case of histone H3, both contribute
to global H3K9 mono- and dimethylation [14]. We show
here that a similar situation occurs for H1, where both
enzymes target identical lysines.
Interestingly, both G9a and Glp1 were able to methylate
H1 in a variant-specific way. In H1.4, the main methyla-
tion site is K26 in the N-terminus, whereas in H1.2 (and
the other main somatic H1 variants H1.0, H1.3 and H1.5)
it is the C-terminus that is preferentially methylated by
G9a and Glp1. Methylation of H1.2 at K26 had previously
been identified only at low levels by MS in certain mouse
tissues, but according to our data this seems not to be a
G9a target. Indeed, H1.2K26 can be methylated by other
enzymes such as Ezh2 ([18] and our unpublished data).
Furthermore, H1.4K26me2 is specifically bound by all
HP1 isoforms, but K187me2 is not, and only
H1.4K26me2 is demethylated by JMJD2D. Both of these
features thus distinguish these two methylation marks.
In our MS analysis we detected monomethylation of
H1.2K187 in vivo, but dimethylation of H1.2K187 might
have escaped our MS analysis if it was below our current
detection threshold. Both enzymes have been shown to
dimethylate H3K9 and H1.4K26 both in vitro and in vivo
[16,24]. In line with this, our assays showed that G9a and
Glp1 methylate unmodified and monomethylated K187
peptides, demonstrating dimethylation activity.
To date, the only characterised modification of the H1
C-terminus is phosphorylation. The C-terminal tail of H1
can be highly phosphorylated [25] on several serine and
threonine residues. This phosphorylation is mainly catal-
ysed by cdk type kinases [26,27], and is highly cell cycle-
dependent, reaching maximum levels in G2/M phase.
Interestingly, in contrast to phosphorylation, H1.2K187
methylation levels remain steady throughout the cell
cycle, suggesting that only H1 C-terminal phosphoryla-
tion, but not H1.2K187 methylation, has a global role in
mitotic chromosome condensation [28]. In a recent MS
analysis [3,4,18,29] a phosphorylation site, S188, was
mapped next to K187 in H1.4 but not H1.2. Although it is
tempting to speculate that S188 phosphorylation might
block K187 methylation in H1.4, there are strong argu-
ments against this. First, the C-terminus of recombinant,
unphosphorylated H1.4 is not (or only very weakly)
methylated by G9a/Glp1 and second, only the neighbour-
ing phosphorylation is cell cycle-dependent.
Whether H1 variants have specific functions is a matter
of an ongoing debate [3,4,29]; however, there are several
lines of evidence pointing towards specific functions. Flu-
orescence recovery after photobleaching experiments
showed that different H1 variants span a broad range of
recovery times, owing to significant differences in their
binding affinity to chromatin [3,4,29]. The recovery time
depends on the length of the C-terminal tail, on the den-
sity of positively charged amino acids, and on the number
and distribution of phosphorylation sites within it. H1.2
has one of the shortest tails and the fastest recovery time,
whereas H1.4 shows higher affinity for chromatin with
longer residence times [8]. Recently, differences in the
binding affinities of mammalian H1 variants have also
been shown both in vitro [30] and in vivo [31]. Addition-
ally, a preferential location of H1 variants to different
genomic regions was described [8]. Both the differences
in the dynamics and the reported variations in global
nuclear distribution patterns suggest that H1 variants
such as H1.2 and H1.4 (the major H1 variants in many
somatic cells) could have specific functions. This is sup-
ported by our findings that different methylation sites
t a r g e t ed  b y  t h e  s a m e  e n zym e s  o n  d i s t i n ct  H 1  va ria n ts
have specific readouts.
In addition to G9a/Glp1, H1.4K26 can be methylated by
Ezh2 as part of the polycomb repressive complex 2
(PRC2) [22]; however, the relative in vivo contribution of
these enzymes is currently unclear. Inhibition of G9a and
Glp1 results in a strong decrease in H1.4K26 methylation
[16], suggesting that G9a/Glp1 might be the main
enzymes catalysing this modification. This is in line with
our knockdown experiments showing that reduced levels
of G9a and Glp1 drastically affect H1.4K26me (see Addi-
tional file 2).
Pinpointing a cellular phenotype to histone modifica-
tions in mammals is not straightforward, because amino
acid substitutions cannot be applied by genetic
approaches and also because the enzymes catalyzing
modifications often modify multiple proteins. The phe-
notype of the G9a/Glp1 knockout is embryonically lethal
[24]; however, it is unclear whether this is due to changesWeiss et al. Epigenetics & Chromatin 2010, 3:7
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in the histone modifications or in other G9a/Glp1 targets
[32]. In an attempt to investigate the cellular function of
H1.2K187, we made stable cell lines expressing tagged
wild-type H1.2K187 and a H1.2K187R mutant that can-
not be methylated. Because depletion of H1.2 has been
shown to result in cell-cycle arrest in G1 phase [31], we
checked particularly for possible effects on the cell cycle;
however, we did not detect any major effect on the cells
or on cell-cycle progression, which is in line with
H1.2K187 methylation levels remaining rather steady
throughout the cell cycle.
Interestingly, H1.4K26 methylation by G9a has been
shown to increase the residence time of H1.4 on chroma-
tin [16], whereas the more 'dynamic' H1.2 is not methy-
lated by G9a at this site. Because both G9a and Glp1 are
important for H3K9 methylation and silencing of euchro-
matic genes [14,24], and because H1.2 has been found to
be enriched in euchromatic regions [7,8], we speculate
that H1.2K187 methylation might have a role in gene
silencing in these regions. By contrast, H1.4 has been
found to be enriched in heterochromatic regions [7], and
methylated H1.4K26 but not H1.2K187 can be specifi-
cally bound by HP1 [20], a main component of hetero-
chromatin. This might argue for a role of H1.4K26
methylation in transcriptional repression in heterochro-
matin. It will be interesting in the future to determine the
biological functions and the localisation patterns of the
H1 variants and their corresponding modifications at a
genome-wide level. To date, in spite of many attempts
and different approaches, we have been unable to raise a
satisfactory antibody with unique specificity for methy-
lated H1.2K187 that could be used in in vivo experiments.
It has been reported that the ankyrin repeats of G9a
and Glp1 recognise H3K9me1/2 [33], and suggested that
they also bind to H1.4K26me1/2 [16], contributing to
their recruitment to chromatin. We do not observe bind-
ing of G9a or Glp1 to methylated H1.4K26 or H1.2K187
peptides, suggesting a different recruiting mechanism
from that for H3K9me1/2. Moreover, recruitment of
G9a/Glp1 to H3K9me1/2 could result in the spreading of
H3K9 methylation mark, whereas our data suggest that
such a mechanism is less likely for H1. This is in line with
the globally low levels of H1 methylation, compared with
H3K9me1/2; however, binding of the ankyrin repeats to
H3K9me1/2 could tether G9a/Glp1 and then direct H1
methylation.
Conclusions
In conclusion, we have identified and characterised a
novel methylation site in the C-terminus of histone H1
(H1.2K187). We have shown that the HKMTs G9a and its
interacting partner Glp1 are the enzymes performing this
methylation in vitro and in vivo, resulting in the identifi-
cation of the first enzymes that methylate the H1 C-ter-
minus and of a new G9a/Glp1 target. Furthermore, we
have demonstrated that the HKMTs G9a and Glp1 can
methylate histone H1 in a variant-specific manner in the
N- or C-terminus. To our knowledge, this is the first
example of variant-specific histone modifications by the
same enzymes. Additionally H1.4K26me and
H1.2K187me also differ in their readout, clearly distin-
guishing them functionally.
Methods
Cluster mutation PCR
For the exchange of lysine clusters, two-step mutagenesis
PCR was used. Mutation primers consisted of the 18
replacing bases and approximately 20 bases complemen-
tary to the template. In the first PCR, DNA fragments
covering the 5' end to the mutation site and the mutation
site to the 3' end were amplified separately in two reac-
tions. In the second PCR, the two products were mixed
and primers flanking the 5' and 3' ends were used to
amplify the complete mutated DNA fragment.
Protein expression and purification
Recombinant human HKMTs ((numbers are amino acid
residues) Glp1 610-917; Nsd2 926-1210; PRDM5 3-429;
MLL5 294-481; Nsd1 1700-1987; BLIMP1 105-323; PR-
SET7 FL; SMYD2 FL; SMYD4 FL; Suv39h1 82-412;
Suv39h2 157-477; Suv39h1 82-412 H320R; SMYD3 FL;
SMYD5 FL; G9a 682-1000; Suv4-20h1 1-384; Suv4-20h2
1-280; plasmids obtained from T. Jenuwein) were
expressed as glutathione S-transferase (GST) fusion pro-
teins in bacteria using standard techniques and purified
(glutathione Sepharose® 4B; GE Healthcare, Piscataway,
NJ, USA).
Affinity purification of bacterially expressed 2× z-
tagged and histidine (His)-tagged H1 was performed
(HIS-Select Nickel Affinity Gel; Sigma, St Louis, MO,
USA). C-terminally His-tagged recombinant histone H1
was extracted from bacteria with 0.83 M perchloric acid
(PCA) and then neutralized by addition of Tris/HCl pH
9.5. Further purification was achieved using nickel affin-
ity gel (Sigma).
For eukaryotic expression of human G9a and Glp1,
HEK293 cells were transiently transfected with plasmids
encoding full-length FLAG-tagged G9a or Glp1 using the
calcium-phosphate method and harvested 72 hours after
transfection. Purification was performed using Anti-
FLAG M2 agarose (Sigma).
His-tagged recombinant human JMJD2D (1-350; plas-
mid obtained from Y. Shi) was expressed in bacteria using
standard techniques and purified with nickel affinity gel.
Human FL HP1β and human FL HP1γ (plasmids
obtained from T. Kouzarides) were expressed as GST
fusion proteins in bacteria using standard techniques and
affinity purified (glutathione Sepharose® 4B; GE Health-Weiss et al. Epigenetics & Chromatin 2010, 3:7
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care). Full-length recombinant H1 variants were obtained
from Calbiochem -Novabiochem Corp. (San Diego, CA,
USA).
Purification of endogenous nucleosomes and H1
Approximately 3 × 107 HEK293 cells were swollen in
hypotonic buffer (20 mM HEPES pH 7.0, 20 mM NaCl, 5
mM MgCl2), and plasma membranes were destroyed by
homogenizing in a dounce homogenizer. After centrifu-
gation, the pellet was resuspended in hypotonic buffer
with a final concentration of 0.5% NP-40 (Nonidet P-40
(Fluka AG, Buchs, Switzerland); to lyse nuclei. Chromatin
was pelleted by centrifugation, resuspended in isolation
buffer (10 mM Tris/HCl pH 7.4, 1.5 mM MgCl2, 1 mM
CaCl2, 0.25 M sucrose) and optical density at 260 nm
(OD260) was measured. Micrococcal nuclease (10 U per
50 μg DNA) was added, and the samples were incubated
at 37°C for 1 hour. Mono- and dinucleosomes were
extracted twice with lysis buffer (10 mM Tris/HCl pH
6.85, 5 mM EDTA) and separated by centrifugation for 14
hours at 280 000 g on a 5% to 40% sucrose gradient (20
mM HEPES pH 7.6, 0.5 mM MgCl2, 5% to 40% sucrose).
For endogenous H1 extraction, HEK293 cells were
lysed in Triton extraction buffer (1 × phosphate-buffered
saline (PBS) with 0.5% triton ×100) to remove the cytosol.
After pelleting of nuclei, H1 was extracted with 0.83 M
PCA.
In vitro methylation assay
HKMT assays were carried out as previously described
[34]. Briefly, in a total volume of 25 μl, 2-10 μl of purified
full-length G9a or Glp1 or recombinant GST fusion
enzymes were mixed with 2 μg of recombinant histone
H1 or 10 μg of peptides as substrate (H1.2K187 peptides
PKKAAK187SAAKAVGC with K187 either unmodified
(UM), monomethylated (me1) or dimethylated (me2),
H1.4K26 peptides VKKKARK26SAGAAKGC with K26
either unmodified or dimethylated) (peptides obtained
from CloneStar Peptide Services (Brno, Czech Republic)
and GeneCust Europe (Dudelang, Luxembourg)). Reac-
tions were carried out in Tris (20 mM Tris/HCl pH 9.0),
phosphate (10 mM Na2HPO4, 2 mM KH2PO4, 2.7 mM
KCl, 137 mM NaCl, pH 7.2), R (50 mM Tris/HCl pH 8.5,
5 mM MgCl2) or Methylation Assay Buffer (MAB) (50
mM Tris/HCl pH 8.5, 20 mM KCl, 10 mM MgCl2, 0.25
mM sucrose) buffers at 30°C for 1 hour. H1 was then sep-
arated using SDS-PAGE with 15% to 18.7% gels, and pep-
tides were resolved in 16% Schägger Jagow gels. Proteins
and peptides were transferred to nitrocellulose mem-
branes and exposed to film (BioMax MS; Kodak).
In vitro demethylation assay and subsequent 
remethylation assay
For the demethylation assay, 20 μl of purified recombi-
nantly expressed JMJD2D and 25 μg of peptide were
mixed in reaction buffer (50 mM Tris/HCl pH 7.4, 1 mM
α-ketoglutarate, 2 mM ascorbate and 70 μM
Fe2+(NH4)2(SO4)2), and demethylation was performed
at 37°C for 6 hours. For subsequent remethylation, 15 μl
of the demethylation assay mixture were added to 1 μl of
1 M Tris/HCl pH 9.5, 9.4 μl of mixed purified G9a and
Glp1, 0.6 μl 0.5 M EDTA (final concentration 10 mM) and
4 μl 5× R methylation buffer, and then incubated at 32°C
for 1 hour. Peptides were separated in 16% Schägger
Jagow gels, transferred to nitrocellulose membrane and
exposed to film (BioMax MS).
Knockdown of G9a and Glp1 and reverse transcriptase PCR
Briefly, 4 × 106 HEK293 cells were plated in a 145 mm
dish. The following day, the cells were simultaneously
transfected according to the manufacturer's instructions,
using a mix containing 100 μl of 10 mM anti-Glp1 small
interfering (si)RNA (AACGAAGAATGGGAACCTATA)
(Qiagen, Valencia, CA, USA), 100 μl anti-G9a siRNA
(CACCATGAACATCGATCGCAA) (Qiagen) and 100 μl
of lipofectamine for double knockdown. Control cells
were transfected with 200 μl 10 mM negative siRNA (All-
Stars; Qiagen). The mRNA levels of cells harvested after
19, 42 and 72 hours were analysed by reverse tran-
scriptase PCR using a commercial kit (RevertAid Minus
First Strand cDNA Synthesis Kit; Fermentas Inc., Glen
Burnie, MD, USA) and the following primers: CTGACA-
CAGAGGACAGGAAGC and TCTCGAACTTCTCTG-
GGATCTT for Glp1; TCCGACAGCAAGTCTGAAGTT
and TGACTGATTCCCTGACTCCTC for G9a; CGGT-
TGGCCTTGGGGTTCAGGGGG and ATCGTG-
GGGGCGCCCCAGGCACCA for β-actin (used as
control). For MS analysis, cells were harvested after 72
hours.
Peptide affinity purification
Peptides were coupled to a gel (SulfoLink Coupling Gel;
Pierce, Rockford, IL, USA) via their C-terminal cysteine
according to the manufacturer's instructions. Recombi-
nant HP1β and γ or HeLa nuclear extracts were added to
20 μl of coupled beads and incubated for 90 minutes at
4°C. Beads were washed three times with IPH-X buffer
(20 mM Tris/HCl pH 8.0, 0.5% NP-40, NaCl 250 mM or
as indicated) before elution and separation on 15% SDS-
PAGE gels. As indicated, binding was detected by either
Coomassie staining or immunostaining using HP1 -spe-
cific antibody (10478; Abcam, Cambridge, MA, USA) or
Glp1-specific antibody (D220-3; MBL International,
Woburn, MA, USA).Weiss et al. Epigenetics & Chromatin 2010, 3:7
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Mass spectrometry
Acid-extracted histones were diluted in 100 mM ammo-
nium bicarbonate buffer (pH 8.0) and digested with
trypsin at a protein:substrate ratio of 15:1 for 8 hours at
37°C. The reaction was quenched by acidification to pH
3.0 with glacial acetic acid and freezing. The digestion
was then reacted with either D0- or D5-propionic anhy-
dride [35] for chemical derivatization labelling and incor-
poration of a stable isotope label for quantitative
comparison as previously described (Plazas-Mayorca et
al., submitted for publication). Samples were separated
by online reverse-phase liquid chromatography followed
by analysis in an orbitrap mass spectrometer operated in
the data-dependent mode as previously described [36].
All spectra were manually verified.
Cell-cycle synchronization
Exponentially growing HEK293 cells were synchronised
in M phase by treatment with 300 ng/ml nocodazole for
18 h. Cells were enriched in G1/G0 phase by serum star-
vation in DMEM containing 0,5% FCS for 48 h. Cell-cycle
distribution was checked by propidium iodide staining
and fluorescence activated cell sorting.
Chymotrypsin digestion
For chymotrypsin digestion, 4 μl of 3 M Na acetate pH 4.8
and 60 ng chymotrypsin (A-Chymotrypsin Type I-S;
S i g m a )  w e r e  a d d e d  t o  2 5  μ l  o f  m e t h y l a t i o n  a s s a y ,  a n d
digestion was performed at 25°C for 20 minutes. Frag-
ments were separated in 18.7% SDS-PAGE gels, trans-
ferred to nitrocellulose membrane and exposed to film
(BioMax MS).
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Additional file 1 Figure S1 - Recombinant PRSET7 and Suv4-20h1 
methylate H4. (a) Coomassie staining of membrane with histones used for 
Figure 1a. (b) Autoradiography of HKMT assay with PRSET7 and Suv4-20h1 
is shown as specificity control of our assays.
Additional file 2 Figure S2 - Quantitative mass spectrometry analysis 
of G9a/Glp1 knockdown versus control samples. Full mass spectra 
showing peptides from (a) H4K20me2, (b) H3K27me2, (c) H3K9me2 and (d) 
H1.4K26me1. No changes in H4K20me2 or H3K27me2 were detected, but 
decreases in H3K9me2 and H1.4K26me1 were seen in the G9a/Glp1 knock-
down samples.
Additional file 3 Figure S3 - Loading control of digested H1 variants. 
Coomassie loading control for Fig 4D. H1 variants were methylated by G9a/
Glp1 and afterwards digested by Chymotrypsin. One part of the samples 
was loaded on an SDS gel and afterwards transferred to a nitrocellulose 
membrane for autoradiography (Fig 4d), the other part of the samples was 
loaded on an SDS gel and stained with Coomassie to serve as a loading 
control.
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